These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9154946)

  • 1. Proton magnetic resonance spectroscopy of blood plasma in heart transplant recipients treated with cyclosporine: an early prognosis test of long-term graft tolerance.
    Le Floch M; Ramee MP; LeLong B; Leray G; Kerbaol M; de Certaines JD
    J Heart Lung Transplant; 1997 Apr; 16(4):381-6. PubMed ID: 9154946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M; Pelletier GB; Tan A; Jesina C; Carrier M
    J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of surveillance biopsies in infant heart transplant recipients.
    Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation.
    Barnard JB; Thekkudan J; Richardson S; Bittar MN; Martyszczuck R; Hasan J; Khasati N; Keevil B; Yonan N
    J Heart Lung Transplant; 2006 May; 25(5):564-8. PubMed ID: 16678036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electric myocardial impedance registration in humoral rejection after heart transplantation.
    Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
    J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
    Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
    Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
    Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
    J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
    Waid TH; Thompson JS; McKeown JW; Brown SA; Sekela ME
    J Heart Lung Transplant; 1997 Sep; 16(9):913-6. PubMed ID: 9322140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
    Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation.
    Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC
    Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen.
    Nohria A; Ehtisham J; Ramahi TM
    J Heart Lung Transplant; 1998 Sep; 17(9):849-53. PubMed ID: 9773855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early screening for antibody-mediated rejection in heart transplant recipients.
    Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
    J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.